for

Metabolon Collaborates with The Michael J. Fox Foundation to Advance Multiomic Analyses for Parkinson’s Research

Partnership supports expanded biomarker discovery efforts within MJFF's Parkinson's Progression Markers InitiativeMORRISVILLE, N.C., March 17, 2026 /PRNewswire/ -- Metabolon, Inc.,…

2 months ago

2026 MAP Awards presented to 20 organizations for high performance in revenue cycle

CHICAGO, March 18, 2026 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) announced the 2026 winners of the MAP…

2 months ago

Bengaluru-based TerraTern Emerges As a Global Hub for AI-Powered Immigration, Work & Study Abroad Guidance

BANGALORE, India, March 17, 2026 /PRNewswire/ -- Since the advent of artificial intelligence is transforming global mobility and global education…

2 months ago

HCLTech named as one of the World’s Most Ethical Companies by Ethisphere for third consecutive year

NEW YORK and NOIDA, India, March 18, 2026 /PRNewswire/ -- HCLTech (NSE: HCLTECH) (BSE: HCLTECH), a leading global technology company,…

2 months ago

Aircom Unveils raNora, Its Agentic AI Platform For Autonomous Networks

Aircom introduces telco-trained multi-agent AI platform designed to bring agentic execution into real radio network workflows, bridging the gap between…

2 months ago

Lantronix to Showcase Intelligent PoE Infrastructure and Edge AI Solutions for Autonomous Systems at ISC West 2026

IRVINE, Calif., March 17, 2026 (GLOBE NEWSWIRE) -- Lantronix Inc. (Nasdaq: LTRX), a global provider of Edge AI and Industrial…

2 months ago

Phillips Connect Introduces Platform Enhancements for Connected Trailers

NASHVILLE, Tenn., March 15, 2026 (GLOBE NEWSWIRE) -- Phillips Connect today announced new platform enhancements designed to expand how fleets…

2 months ago

G6 Hospitality and Fort Worth Police Department Organise Safe Hospitality Seminar for Franchisees

March 15, 2026 06:05 ET  | Source: G6 Hospitality LLC DALLAS, March 15, 2026 (GLOBE NEWSWIRE) -- G6 Hospitality, the…

2 months ago

Biomea Fusion Presents Phase II COVALENT-111 Data in Type 2 Diabetes at the 19th International Conference on Advanced Technologies & Treatments for Diabetes 2026

SAN CARLOS, Calif., March 14, 2026 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea,” “Biomea Fusion,” or the “Company”) (Nasdaq: BMEA),…

2 months ago

Novartis Cosentyx receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa

Cosentyx is the only IL-17A inhibitor approved for this population, and the first differentiated mechanism in nearly a decade1-3 HS often emerges around…

3 months ago